Lithium as a neuroprotective agent for bipolar disorder: an overview
ELM Ochoa - Cellular and molecular neurobiology, 2022 - Springer
Lithium (Li+) is a first option treatment for adult acute episodes of Bipolar Disorder (BD) and
for the prophylaxis of new depressed or manic episodes. It is also the preferred choice as …
for the prophylaxis of new depressed or manic episodes. It is also the preferred choice as …
Lithium as a Neuroprotective Agent for Bipolar Disorder: An Overview.
ELM Ochoa - Cellular and Molecular Neurobiology, 2021 - europepmc.org
Lithium (Li+) is a first option treatment for adult acute episodes of Bipolar Disorder (BD) and
for the prophylaxis of new depressed or manic episodes. It is also the preferred choice as …
for the prophylaxis of new depressed or manic episodes. It is also the preferred choice as …
Lithium as a Neuroprotective Agent for Bipolar Disorder: An Overview
ELM Ochoa - Cellular and molecular neurobiology, 2022 - pubmed.ncbi.nlm.nih.gov
Lithium (Li+) is a first option treatment for adult acute episodes of Bipolar Disorder (BD) and
for the prophylaxis of new depressed or manic episodes. It is also the preferred choice as …
for the prophylaxis of new depressed or manic episodes. It is also the preferred choice as …
Lithium as a Neuroprotective Agent for Bipolar Disorder: An Overview.
ELM Ochoa - Cellular & Molecular Neurobiology, 2022 - search.ebscohost.com
Abstract Lithium (Li< sup>+</sup>) is a first option treatment for adult acute episodes of
Bipolar Disorder (BD) and for the prophylaxis of new depressed or manic episodes. It is also …
Bipolar Disorder (BD) and for the prophylaxis of new depressed or manic episodes. It is also …